The development of proposals for the Society of Toxicology (SOT) 2018 Annual Meeting is underway with deadlines for pre-review by many Specialty Sections (SS) beginning in mid-April 2017 and deadline to submit proposals online to SOT on May 15, 2017. The SS Collaboration and Communication Group (SS-CCG), which represents all SOT SSs, has compiled a list of individuals serving as contacts for Session Proposal Pre-Review for SOT 2018.
As stated on the SOT webpage on preparing proposals for SOT 2018 found here, proposals that have undergone the editing and refinement process with potential endorsers prior to submission tend to receive higher scores and ranks during the review. A pre-review also allows you to gauge the level of interest of the SS as a potential endorser. Below is a list of contacts with their email addresses and deadlines by which your submission should be provided for this pre-review process. Please be advised that a session pre-review is not a guarantee that the session proposal will be endorsed by the SS.
If you are putting together a 2018 SOT Scientific Session Proposal that is especially diverse (e.g., spans interests of 4+ SSs, or the transdisciplinary focus does not align with current SS boundaries), you may send pre-submission inquiries to the SS-CCG by April 24, 2017, to Jeff Moffit (jeff.moffit@bioverativ.com) to determine whether the SS-CCG would be a good choice as a potential endorser. The SS-CCG expects to provide endorsement to a limited number of session proposals, as SS-CCG endorsement is not intended to replace appropriate SS review.
|
|
|
|
| Specialty Section |
Pre-Review Contact |
Position |
Deadline for Pre-Review Requests |
| Biological Modeling |
Jeff Gearhart |
Vice President |
5/1/2017 |
| Biotechnology |
Jorg Blumel​ |
Vice President |
5/1/2017 |
| Carcinogenesis |
Robert Schiestl |
President |
5/1/2017 |
| Carcinogenesis |
|
Vice President |
5/1/2017 |
| Carcinogenesis |
|
Vice President-Elect |
5/1/2017 |
| Carcinogenesis |
|
Secretary/Treasurer |
5/1/2017 |
| Carcinogenesis |
|
Past President |
5/1/2017 |
| Carcinogenesis |
|
Councilor |
5/1/2017 |
| Carcinogenesis |
|
Councilor |
5/1/2017 |
| Cardiovascular Toxicology |
Dinah Misner |
Treasurer |
4/30/2017 |
| Clinical and Translational Toxicology |
Jiri Aubrecht |
President |
5/7/2017 |
| Clinical and Translational Toxicology |
Donna Mendrick |
Vice President |
5/7/2017 |
| Clinical and Translational Toxicology |
John-Michael Sauer |
Vice President-Elect |
5/7/2017 |
| Comparative and Veterinary |
Jackie Akunda |
Vice President |
4/28/2017 |
| Dermal Toxicology |
Neera Tewari-Singh |
Secretary/Treasurer |
5/1/2017 |
| Drug Discovery Toxicology |
Peter Newham |
Vice President |
5/1/2017 |
| Ethical, Legal, and Social Issues |
Esther Haugabrooks |
Councilor |
4/12/2017 |
| Food Safety |
Karin Ke |
Vice President |
5/1/2017 |
| Immunotoxicology |
Rodney Prell |
Councilor |
5/1/2017 |
| In Vitro and Alternative Methods |
Barbara Wetmore |
Vice President |
4/24/2017 |
| In Vitro and Alternative Methods |
Amy Clippinger |
President |
4/24/2017 |
| In Vitro and Alternative Methods |
Warren Casey |
Vice President-Elect |
4/24/2017 |
| In Vitro and Alternative Methods |
Katie-Paul Friedman |
Councilor |
4/24/2017 |
| Inhalation and Respiratory |
Laura Van Winkle |
Secretary/Treasurer |
5/1/2017 |
| Mechanisms |
Rhiannon Hardwick |
Secretary/Treasurer |
4/24/2017 |
| Medical Device |
Kelly Coleman |
President |
5/1/2017 |
| Metals |
Erik Tokar |
Vice President |
5/1/2017 |
| Mixtures |
Danielle Carlin |
Program Committee |
5/1/2017 |
| Molecular and Systems Biology |
Shaun McCullough |
Vice President-Elect |
5/1/2017 |
| Nanotoxicology |
Aaron Erdely |
Vice President (Chair of Nano-SS Program Committee) |
5/7/2017 |
| Neurotoxicology |
Mary Gilbert |
Vice President |
4/15/2017 |
| Occupational and Public Health |
Amanda Persad |
Vice President-Elect |
5/1/2017 |
| Ocular Toxicology |
Chris Somps |
President |
4/21/2017 |
| Ocular Toxicology |
Mercedes Salvador-Silva |
Vice President |
4/21/2017 |
| Ocular Toxicology |
Vasudev Anand |
Vice President-Elect |
4/21/2017 |
| Ocular Toxicology |
Marcus Terneus |
Communications Officer |
4/21/2017 |
| Ocular Toxicology |
Russell Eyre |
Treasurer |
4/21/2017 |
| Ocular Toxicology |
Evan Thackaberry |
Past President |
4/21/2017 |
| Ocular Toxicology |
Vladimir Bantseev |
Councilor |
4/21/2017 |
| Ocular Toxicology |
Brian Gilger |
Councilor |
4/21/2017 |
| Regulatory and Safety Evaluation |
Edward Ohanian |
Vice President |
5/5/2017 |
| Regulatory and Safety Evaluation |
Marie Fortin |
Vice President-Elect |
5/5/2017 |
| Regulatory and Safety Evaluation |
Elizabeth Vancza |
Chair, Proposal Review Committee |
5/5/2017 |
| Reproductive and Developmental Toxicology |
Kary Thompson |
Vice President |
4/3/2017 |
| Risk Assessment |
Sean Hays |
President |
5/1/2017 |
| Stem Cells |
Erik Tokar |
Past President |
5/1/2017 |
| Toxicologic and Exploratory Pathology |
Angela Wilcox |
Vice President |
5/1/2017 |
|
|
|
|
|
|
|
|